nodes	percent_of_prediction	percent_of_DWPC	metapath
Ingenol Mebutate—PRKCA—exocrine gland—esophageal cancer	0.0394	0.178	CbGeAlD
Ingenol Mebutate—PRKCD—bronchus—esophageal cancer	0.0306	0.139	CbGeAlD
Ingenol Mebutate—PRKCD—trachea—esophageal cancer	0.0275	0.124	CbGeAlD
Ingenol Mebutate—PRKCA—neck—esophageal cancer	0.0252	0.114	CbGeAlD
Ingenol Mebutate—PRKCD—lung—esophageal cancer	0.0197	0.0894	CbGeAlD
Ingenol Mebutate—PRKCA—epithelium—esophageal cancer	0.0171	0.0776	CbGeAlD
Ingenol Mebutate—PRKCA—smooth muscle tissue—esophageal cancer	0.0165	0.0747	CbGeAlD
Ingenol Mebutate—PRKCD—lymph node—esophageal cancer	0.0135	0.0611	CbGeAlD
Ingenol Mebutate—PRKCA—digestive system—esophageal cancer	0.013	0.059	CbGeAlD
Ingenol Mebutate—PRKCA—lung—esophageal cancer	0.0109	0.0493	CbGeAlD
Ingenol Mebutate—PRKCA—lymph node—esophageal cancer	0.00744	0.0337	CbGeAlD
Ingenol Mebutate—PRKCA—Mitotic M-M/G1 phases—RB1—esophageal cancer	0.000217	0.000279	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—PIK3CA—esophageal cancer	0.000217	0.000278	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—ABL1—esophageal cancer	0.000215	0.000276	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—PIK3CA—esophageal cancer	0.000214	0.000275	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—ADH1B—esophageal cancer	0.000213	0.000274	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—ALDOB—esophageal cancer	0.000211	0.000271	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—LGALS3—esophageal cancer	0.000211	0.000271	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—SMAD4—esophageal cancer	0.00021	0.00027	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—BCL2—esophageal cancer	0.000209	0.000268	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—FKBP1A—esophageal cancer	0.000208	0.000267	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—EGFR—esophageal cancer	0.000208	0.000267	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—EGFR—esophageal cancer	0.000208	0.000267	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—PIK3CA—esophageal cancer	0.000207	0.000266	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CTNNA1—esophageal cancer	0.000207	0.000266	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—EGFR—esophageal cancer	0.000206	0.000265	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—TGFBR2—esophageal cancer	0.000206	0.000264	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CXCL2—esophageal cancer	0.000206	0.000264	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—ANXA1—esophageal cancer	0.000205	0.000263	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—ERBB2—esophageal cancer	0.000204	0.000262	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—EGFR—esophageal cancer	0.000204	0.000262	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—TYMP—esophageal cancer	0.000204	0.000262	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—WIF1—esophageal cancer	0.000203	0.000261	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—EGFR—esophageal cancer	0.000203	0.000261	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—HIST1H2BM—esophageal cancer	0.000203	0.000261	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—GAPDH—esophageal cancer	0.000203	0.000261	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—ERBB2—esophageal cancer	0.000203	0.00026	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	0.0002	0.000257	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—CXCL2—esophageal cancer	0.0002	0.000257	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—SST—esophageal cancer	0.000199	0.000256	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—CYP26A1—esophageal cancer	0.000198	0.000255	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Insulin Signaling—PIK3CA—esophageal cancer	0.000196	0.000251	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	0.000196	0.000251	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—SMAD4—esophageal cancer	0.000195	0.00025	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—PIK3CA—esophageal cancer	0.000195	0.00025	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—GHRL—esophageal cancer	0.000194	0.000249	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—PIK3CA—esophageal cancer	0.000194	0.000249	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—ALOX15—esophageal cancer	0.000193	0.000248	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—PIK3CA—esophageal cancer	0.000193	0.000247	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PSME2—esophageal cancer	0.000192	0.000247	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PSME1—esophageal cancer	0.000192	0.000247	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—PIK3CA—esophageal cancer	0.000192	0.000246	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—ANXA1—esophageal cancer	0.000191	0.000245	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CSNK1A1—esophageal cancer	0.000188	0.000241	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—ACTB—esophageal cancer	0.000187	0.00024	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—SST—esophageal cancer	0.000186	0.000239	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—ANXA1—esophageal cancer	0.000186	0.000239	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—GSTO1—esophageal cancer	0.000184	0.000237	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—TPI1—esophageal cancer	0.000184	0.000237	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—EGFR—esophageal cancer	0.000184	0.000236	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—EP300—esophageal cancer	0.000183	0.000235	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—PTPN2—esophageal cancer	0.000183	0.000235	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—NOTCH3—esophageal cancer	0.000181	0.000233	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—GHRL—esophageal cancer	0.000181	0.000233	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—SST—esophageal cancer	0.000181	0.000232	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—B2M—esophageal cancer	0.000181	0.000232	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—PIK3CA—esophageal cancer	0.000181	0.000232	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—PIK3CA—esophageal cancer	0.000181	0.000232	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—XIAP—esophageal cancer	0.000179	0.00023	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—PIK3CA—esophageal cancer	0.000179	0.00023	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—FBXW7—esophageal cancer	0.000178	0.000229	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—esophageal cancer	0.000178	0.000228	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—PIK3CA—esophageal cancer	0.000177	0.000228	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—ALDOB—esophageal cancer	0.000177	0.000227	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—PIK3CA—esophageal cancer	0.000177	0.000227	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—GHRL—esophageal cancer	0.000176	0.000226	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PFN1—esophageal cancer	0.000176	0.000225	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—CDKN1A—esophageal cancer	0.000175	0.000224	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—CDKN1A—esophageal cancer	0.000173	0.000223	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—NOS2—esophageal cancer	0.000172	0.000221	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—PSME2—esophageal cancer	0.000171	0.000219	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—PSME1—esophageal cancer	0.000171	0.000219	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—GAPDH—esophageal cancer	0.00017	0.000218	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	0.00017	0.000218	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—PSME2—esophageal cancer	0.00017	0.000218	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—PSME1—esophageal cancer	0.00017	0.000218	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—HSPA5—esophageal cancer	0.000169	0.000217	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—CRABP1—esophageal cancer	0.000169	0.000216	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—B2M—esophageal cancer	0.000167	0.000214	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—TLR4—esophageal cancer	0.000165	0.000212	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—EP300—esophageal cancer	0.000165	0.000212	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	0.000164	0.000211	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CALR—esophageal cancer	0.000164	0.00021	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—TLR4—esophageal cancer	0.000163	0.000209	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—NOTCH2—esophageal cancer	0.000163	0.000209	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—RB1—esophageal cancer	0.000163	0.000209	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—GNG7—esophageal cancer	0.00016	0.000206	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—NOTCH3—esophageal cancer	0.00016	0.000206	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—ENO1—esophageal cancer	0.00016	0.000205	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—PIK3CA—esophageal cancer	0.00016	0.000205	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—HIF1A—esophageal cancer	0.00016	0.000205	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—FBXW7—esophageal cancer	0.000158	0.000203	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ELMO1—esophageal cancer	0.000158	0.000202	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PSME1—esophageal cancer	0.000158	0.000202	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PSME2—esophageal cancer	0.000158	0.000202	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—NOTCH1—esophageal cancer	0.000155	0.000199	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—CREBBP—esophageal cancer	0.000155	0.000198	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	0.000154	0.000198	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—AKAP13—esophageal cancer	0.000154	0.000198	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by Wnt—EP300—esophageal cancer	0.000153	0.000196	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—HMGB1—esophageal cancer	0.000151	0.000194	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CALR—esophageal cancer	0.000151	0.000194	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	0.000151	0.000194	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—ALDH2—esophageal cancer	0.00015	0.000193	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—FBXW7—esophageal cancer	0.000146	0.000188	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—RB1—esophageal cancer	0.000145	0.000187	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—NOS2—esophageal cancer	0.000145	0.000186	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TGFBR2—esophageal cancer	0.000144	0.000185	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—NOTCH1—esophageal cancer	0.000144	0.000184	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—NOTCH2—esophageal cancer	0.000144	0.000184	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—GSTT1—esophageal cancer	0.000143	0.000183	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—CDKN2A—esophageal cancer	0.000143	0.000183	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000142	0.000183	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CASP8—esophageal cancer	0.000142	0.000182	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—EGFR—esophageal cancer	0.000142	0.000182	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—CYP2A6—esophageal cancer	0.000141	0.000181	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CREBBP—esophageal cancer	0.000141	0.000181	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PDE4D—esophageal cancer	0.000141	0.000181	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—EGFR—esophageal cancer	0.000141	0.000181	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—CREBBP—esophageal cancer	0.00014	0.00018	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CASP8—esophageal cancer	0.00014	0.000179	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CREBBP—esophageal cancer	0.000139	0.000179	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—NOS3—esophageal cancer	0.000138	0.000178	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—SMAD4—esophageal cancer	0.000137	0.000175	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—PIK3CA—esophageal cancer	0.000136	0.000174	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—GNG7—esophageal cancer	0.000134	0.000172	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—ENO1—esophageal cancer	0.000134	0.000172	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PTGS1—esophageal cancer	0.000134	0.000172	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by Wnt—MYC—esophageal cancer	0.000133	0.000171	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PSME2—esophageal cancer	0.000132	0.000169	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PSME1—esophageal cancer	0.000132	0.000169	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—TP53—esophageal cancer	0.000131	0.000168	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—CREBBP—esophageal cancer	0.00013	0.000167	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—CDKN2A—esophageal cancer	0.000128	0.000164	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—XIAP—esophageal cancer	0.000126	0.000161	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—ABL1—esophageal cancer	0.000125	0.000161	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—PIK3CA—esophageal cancer	0.000123	0.000158	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—PIK3CA—esophageal cancer	0.000122	0.000157	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—BCL2—esophageal cancer	0.000122	0.000156	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—CCND1—esophageal cancer	0.000121	0.000155	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—SMAD4—esophageal cancer	0.000121	0.000155	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—BCL2—esophageal cancer	0.00012	0.000154	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CTNNA1—esophageal cancer	0.000119	0.000153	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—TGFBR2—esophageal cancer	0.000118	0.000152	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—ERBB2—esophageal cancer	0.000118	0.000152	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CXCL2—esophageal cancer	0.000118	0.000152	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—CDKN1A—esophageal cancer	0.000117	0.00015	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—NOS3—esophageal cancer	0.000117	0.00015	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—ERBB2—esophageal cancer	0.000117	0.00015	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—CYP1B1—esophageal cancer	0.000114	0.000146	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—SMAD4—esophageal cancer	0.000112	0.000144	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—HIF1A—esophageal cancer	0.000112	0.000143	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—EP300—esophageal cancer	0.000111	0.000143	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PSME2—esophageal cancer	0.00011	0.000142	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PSME1—esophageal cancer	0.00011	0.000142	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ANXA1—esophageal cancer	0.00011	0.000141	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—ERBB2—esophageal cancer	0.000109	0.00014	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—CCND1—esophageal cancer	0.000108	0.000139	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—CYP19A1—esophageal cancer	0.000107	0.000137	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SST—esophageal cancer	0.000107	0.000137	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—KDR—esophageal cancer	0.000107	0.000137	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—PTGS2—esophageal cancer	0.000107	0.000137	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—EP300—esophageal cancer	0.000105	0.000135	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—CDKN1A—esophageal cancer	0.000104	0.000134	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—GHRL—esophageal cancer	0.000104	0.000134	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NOTCH3—esophageal cancer	0.000104	0.000134	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—FBXW7—esophageal cancer	0.000102	0.000131	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CDKN1A—esophageal cancer	0.000101	0.00013	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—NOTCH1—esophageal cancer	0.000101	0.000129	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CDKN1A—esophageal cancer	9.96e-05	0.000128	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—EP300—esophageal cancer	9.94e-05	0.000128	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—HMOX1—esophageal cancer	9.77e-05	0.000125	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—MYC—esophageal cancer	9.69e-05	0.000124	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—EP300—esophageal cancer	9.61e-05	0.000123	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—TLR4—esophageal cancer	9.49e-05	0.000122	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—EP300—esophageal cancer	9.48e-05	0.000122	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—ABCB1—esophageal cancer	9.38e-05	0.00012	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NOTCH2—esophageal cancer	9.34e-05	0.00012	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—CDKN1A—esophageal cancer	9.33e-05	0.00012	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—HIF1A—esophageal cancer	9.16e-05	0.000118	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CREBBP—esophageal cancer	9.13e-05	0.000117	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—EGFR—esophageal cancer	8.97e-05	0.000115	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—NOTCH1—esophageal cancer	8.89e-05	0.000114	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—EP300—esophageal cancer	8.88e-05	0.000114	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—MYC—esophageal cancer	8.66e-05	0.000111	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—PIK3CA—esophageal cancer	8.57e-05	0.00011	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—NOS2—esophageal cancer	8.34e-05	0.000107	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—MYC—esophageal cancer	8.33e-05	0.000107	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TGFBR2—esophageal cancer	8.29e-05	0.000106	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—NOTCH1—esophageal cancer	8.26e-05	0.000106	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—EGFR—esophageal cancer	8.19e-05	0.000105	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—NOS3—esophageal cancer	8.17e-05	0.000105	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CASP8—esophageal cancer	8.14e-05	0.000105	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CREBBP—esophageal cancer	8.11e-05	0.000104	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—EGFR—esophageal cancer	8.08e-05	0.000104	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—CREBBP—esophageal cancer	8.06e-05	0.000103	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SMAD4—esophageal cancer	7.84e-05	0.000101	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—PIK3CA—esophageal cancer	7.79e-05	0.0001	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—PIK3CA—esophageal cancer	7.78e-05	9.99e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—MYC—esophageal cancer	7.74e-05	9.93e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—ERBB2—esophageal cancer	7.64e-05	9.81e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—EGFR—esophageal cancer	7.57e-05	9.71e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—TP53—esophageal cancer	7.54e-05	9.67e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CREBBP—esophageal cancer	7.49e-05	9.61e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—PIK3CA—esophageal cancer	7.11e-05	9.13e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—TP53—esophageal cancer	7.11e-05	9.13e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—PIK3CA—esophageal cancer	7.01e-05	9e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—BCL2—esophageal cancer	6.99e-05	8.97e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—ERBB2—esophageal cancer	6.79e-05	8.71e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CCND1—esophageal cancer	6.75e-05	8.67e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—NOS3—esophageal cancer	6.7e-05	8.6e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—PIK3CA—esophageal cancer	6.57e-05	8.43e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CDKN1A—esophageal cancer	6.53e-05	8.38e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—HIF1A—esophageal cancer	6.42e-05	8.24e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—CREBBP—esophageal cancer	6.27e-05	8.05e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—ERBB2—esophageal cancer	6.27e-05	8.05e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—EP300—esophageal cancer	6.22e-05	7.98e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—KDR—esophageal cancer	6.14e-05	7.88e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PTGS2—esophageal cancer	6.13e-05	7.87e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CDKN1A—esophageal cancer	5.8e-05	7.45e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NOTCH1—esophageal cancer	5.78e-05	7.42e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—NOS3—esophageal cancer	5.61e-05	7.2e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—EP300—esophageal cancer	5.52e-05	7.09e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MYC—esophageal cancer	5.42e-05	6.95e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CDKN1A—esophageal cancer	5.36e-05	6.88e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—EGFR—esophageal cancer	5.3e-05	6.8e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CREBBP—esophageal cancer	5.24e-05	6.73e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—EGFR—esophageal cancer	5.15e-05	6.61e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PTGS2—esophageal cancer	5.13e-05	6.59e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—EP300—esophageal cancer	5.1e-05	6.54e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—PIK3CA—esophageal cancer	4.92e-05	6.32e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—MYC—esophageal cancer	4.78e-05	6.14e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—EGFR—esophageal cancer	4.71e-05	6.04e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NOS3—esophageal cancer	4.69e-05	6.02e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PIK3CA—esophageal cancer	4.6e-05	5.9e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—PIK3CA—esophageal cancer	4.47e-05	5.74e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TP53—esophageal cancer	4.45e-05	5.71e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—MYC—esophageal cancer	4.44e-05	5.7e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ERBB2—esophageal cancer	4.39e-05	5.63e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—EGFR—esophageal cancer	4.35e-05	5.58e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—EP300—esophageal cancer	4.27e-05	5.48e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—PIK3CA—esophageal cancer	4.08e-05	5.24e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CCND1—esophageal cancer	3.88e-05	4.98e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PIK3CA—esophageal cancer	3.77e-05	4.84e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CDKN1A—esophageal cancer	3.75e-05	4.82e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—EP300—esophageal cancer	3.57e-05	4.58e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PIK3CA—esophageal cancer	3.16e-05	4.05e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MYC—esophageal cancer	3.11e-05	3.99e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—EGFR—esophageal cancer	3.04e-05	3.91e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PIK3CA—esophageal cancer	2.64e-05	3.39e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TP53—esophageal cancer	2.55e-05	3.28e-05	CbGpPWpGaD
